Neurocrine Biosciences (NBIX) Finished Goods (2017 - 2020)
Historic Finished Goods for Neurocrine Biosciences (NBIX) over the last 4 years, with Q4 2020 value amounting to $9.0 million.
- Neurocrine Biosciences' Finished Goods rose 42941.18% to $9.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $9.0 million, marking a year-over-year increase of 42941.18%. This contributed to the annual value of $9.0 million for FY2020, which is 42941.18% up from last year.
- As of Q4 2020, Neurocrine Biosciences' Finished Goods stood at $9.0 million, which was up 42941.18% from $2.3 million recorded in Q1 2020.
- In the past 5 years, Neurocrine Biosciences' Finished Goods registered a high of $9.0 million during Q4 2020, and its lowest value of $533000.0 during Q4 2017.
- Moreover, its 4-year median value for Finished Goods was $1.7 million (2019), whereas its average is $2.2 million.
- Its Finished Goods has fluctuated over the past 5 years, first surged by 5028.14% in 2018, then soared by 42941.18% in 2020.
- Neurocrine Biosciences' Finished Goods (Quarter) stood at $533000.0 in 2017, then soared by 50.28% to $801000.0 in 2018, then skyrocketed by 112.23% to $1.7 million in 2019, then surged by 429.41% to $9.0 million in 2020.
- Its Finished Goods stands at $9.0 million for Q4 2020, versus $2.3 million for Q1 2020 and $1.7 million for Q4 2019.